BRK.B trades at a premium with mixed earnings signals and modest returns, despite outperforming its industry YTD.

Global tech consulting company’s founder, Marco Stefanini to attend Brazil-France Forum as special guest, culminating in high-profile meeting with President Emmanuel Macron. PAR ...

The FcRn-targeted immunotherapy market presents opportunities through innovative biologic treatments blocking FcRn-IgG interactions. This addresses high unmet needs in autoimmune diseases like ...